Wedge Capital Management
IRWD icon

Wedge Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Wedge Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.73M Hold
435,650
– – 0.03% 357
2026
Q2 		$1.83M Sell
435,650
-104,842
-19% -$404K 0.03% 346
2026
Q1 		$1.9M Buy
+540,492
New +$2.22M 0.04% 355
2025
Q1 		– Sell
-289,023
Closed -$1.28M – 526
2024
Q4 		$1.28M Sell
289,023
-25,820
-8% -$105K 0.02% 388
2024
Q3 		$1.3M Buy
+314,843
New +$1.69M 0.02% 388
2023
Q3 		– Sell
-248,755
Closed -$2.65M – 506
2023
Q2 		$2.65M Buy
248,755
+228,193
+1,110% +$2.45M 0.04% 340
2023
Q1 		$216K Buy
20,562
+5,659
+38% +$63.4K ﹤0.01% 398
2022
Q4 		$185K Sell
14,903
-86
-0.6% -$976 ﹤0.01% 406
2022
Q3 		$155K Hold
14,989
– – ﹤0.01% 390
2022
Q2 		$173K Buy
14,989
+15
+0.1% +$177 ﹤0.01% 395
2022
Q1 		$188K Sell
14,974
-3,409
-19% -$39.1K ﹤0.01% 408
2021
Q4 		$214K Buy
18,383
+3,182
+21% +$39K ﹤0.01% 386
2021
Q3 		$199K Buy
15,201
+3,657
+32% +$47.3K ﹤0.01% 387
2021
Q2 		$149K Sell
11,544
-1,793
-13% -$20.5K ﹤0.01% 388
2021
Q1 		$149K Sell
13,337
-4,594
-26% -$48.5K ﹤0.01% 516
2020
Q4 		$204K Buy
+17,931
New +$196K ﹤0.01% 535

Other funds holding IRWD

CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Range Financial Group
Range Financial Group Tigard, Oregon $361M AUM 58.71% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Krilogy Financial
Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return
Magnus Financial Group
Magnus Financial Group New York $1.5B AUM 16.47% 1-Year Est. Return
HB Wealth Management
HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return

Wedge Capital Management's IRWD Position: Q3 2026 in Review

Wedge Capital Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2026 at 435,650 shares worth $1.73M. The position accounts for 0.03% of the portfolio, ranked #357.

Wedge Capital Management first reported a position in IRWD in Q4 2020 and has held it in 16 quarters since. The position peaked at $2.65M in Q2 2023. 29 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Wedge Capital Management held 435,650 shares of Ironwood Pharmaceuticals worth $1.73M as of Q3 2026.
  • Wedge Capital Management left its Ironwood Pharmaceuticals share count unchanged in Q3 2026.
  • Ironwood Pharmaceuticals made up 0.03% of Wedge Capital Management's portfolio in Q3 2026, its #357 holding.
  • Wedge Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
  • Wedge Capital Management's Ironwood Pharmaceuticals position peaked at $2.65M in Q2 2023.
  • 29 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Wedge Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.